TITLE

Training News

PUB. DATE
April 2007
SOURCE
Pharmaceutical Representative;Apr2007, Vol. 37 Issue 4, p22
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on developments related to employee training in the U.S. pharmaceutical industry. Wyeth Pharmaceuticals ranked highest in the list of organizations that excel at human-capital development. The Society of Pharmaceutical and Biotech Trainers will release its biannual benchmark study of learning and development practices in pharmaceutical device companies. A research states that the average length of time pharmaceutical sales trainers stay in their positions in 22.5 months.
ACCESSION #
24619974

 

Related Articles

  • Wyeth launches Bowl of Hygeia lecture series. Levy, Sandra // Drug Topics;9/16/2002, Vol. 146 Issue 18, p64 

    Reports that Wyeth Pharmaceuticals is seeking to increase U.S. pharmacists' awareness of the Bowl of Hygeia Award. Recognition of pharmacists for outstanding community service and leadership; Educational sessions being launched by the company which will take place at meetings of the National...

  • Wyeth to invest $250 million more in local plants.  // Caribbean Business;8/1/2002, Vol. 30 Issue 31, p17 

    Reports on the business expansion of Wyeth Pharmaceuticals Inc. in Puerto Rico. Investment in local plant; Total investments of Wyeth; Approval of the Food and Drug Administration of various products of Wyeth; Total number of employees.

  • COMPANY SPOTLIGHT - Wyeth.  // PharmaWatch: CNS;March 2004, Vol. 3 Issue 3, p22 

    Features pharmaceutical company Wyeth Pharmaceuticals Inc. in the U.S. History of the company; Corporate profits; Global operations.

  • Training News.  // Pharmaceutical Representative;Apr2006, Vol. 36 Issue 4, p23 

    The article offers information about medical training in the U.S. Pharmaceutical companies are planning to increase their training budgets and to increase training in scientific and medical subjects. A study figured that forty percent of the training departments are expected to increase its...

  • Anadin maker shifts top marketers in mid-review. Singh, Sonoo // Marketing Week (01419285);12/19/2002, Vol. 25 Issue 51, p6 

    Reports on the career developments of the sales executives at Wyeth Pharmaceuticals Inc. in Great Britain. Promotion of the category director Mark Cooper; Launch of an advertising campaign; Focus on brand awareness.

  • Grey gets Wyeth's low-dose Prempro.  // Medical Marketing & Media;May2003, Vol. 38 Issue 5, p8 

    Reports on Wyeth Pharmaceuticals Group Inc.'s advertising deal with Grey Healthcare Group Inc. concerning the lower-dose version of menopause drug Prempro.

  • How to Win Friends, Influence People and Make NMEs. Lam, Michael D. // Pharmaceutical Executive;Aug2004, Vol. 24 Issue 8, p48 

    Reports on the success of the research and development program of Wyeth Pharmaceuticals. Consumer brands of the company; Hormone therapy products. INSETS: Adding by Subtracting;Balloon Mortgage.

  • FOCUSED DEVELOPMENT LEADS TO GLOBAL SUCCESS. Waitkoff, Megan // Food & Drug Packaging;Dec2007, Vol. 71 Issue 11, p24 

    The article discusses efforts by Wyeth Pharmaceutical to achieve excellence in design and production to increase efficiency and promote growth. The global manufacturing organization is composed of several operational units, including pharmaceuticals and biotechnology. Wyeth has been able to...

  • Effexor ad draws warning letter. Iskowtiz, Marc // Medical Marketing & Media;Jan2008, Vol. 43 Issue 1, p12 

    The article reports on the misleading issues caused by advertisement involving anti-depression pill Effexor XR by Wyeth Pharmaceuticals Inc. A warning letter from the Division of Drug Marketing, Advertising and Communications chief Tom Abrams highlights that the drug is superior to other...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics